Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit the Philadelphia chromosome and the related oncoprotein BCR-ABL1. Allogeneic stem cell transplantation (allo-SCT) was considered the first-line treatment for CML, before the introduction of tyrosine kin...

Full description

Bibliographic Details
Main Authors:	Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud, Bjørn Tore Gjertsen
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Case Reports in Hematology
Online Access:	http://dx.doi.org/10.1155/2018/2045985

Similar Items

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
by: Håkon Reikvam, et al.
Published: (2017-09-01)

Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications
by: Håkon Reikvam, et al.
Published: (2011-01-01)

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T<sub>C</sub>1, T<sub>H</sub>1, T<sub>H</sub>17 and T<sub>REG </sub>cells
by: Gjertsen Bjørn, et al.
Published: (2010-07-01)

Myeloid Sarcoma after Allogenic Stem Cell Transplantation for Acute Myeloid Leukemia: Successful Consolidation Treatment Approaches in Two Patients
by: Silje Johansen, et al.
Published: (2018-01-01)

Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
by: Øystein Bruserud, et al.
Published: (2021-05-01)

Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells
by: Hovland Randi, et al.
Published: (2007-05-01)

The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine&#8212;The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell Transplantation
by: Øystein Bruserud, et al.
Published: (2013-02-01)

The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles
by: Elise Aasebø, et al.
Published: (2020-06-01)

A subset of patients with acute myeloid leukemia has leukemia cells characterized by chemokine responsiveness and altered expression of transcriptional as well as angiogenic regulators
by: Annette Katharina Brenner, et al.
Published: (2016-05-01)

Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
by: Annette K. Brenner, et al.
Published: (2014-11-01)

Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation
by: Tor Henrik Tvedt, et al.
Published: (2016-11-01)

The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia
by: Silje Johansen, et al.
Published: (2018-01-01)

High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype
by: Håkon Reikvam, et al.
Published: (2019-07-01)

CDC25 Inhibition in Acute Myeloid Leukemia–A Study of Patient Heterogeneity and the Effects of Different Inhibitors
by: Annette K. Brenner, et al.
Published: (2017-03-01)

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia
by: Kristine Yttersian Sletta, et al.
Published: (2021-03-01)

Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis
by: Marte Karen Brattås, et al.
Published: (2018-11-01)

S100 Proteins in Acute Myeloid Leukemia
by: Annette K. Brenner, et al.
Published: (2018-12-01)

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation
by: Anette Lodvir Hemsing, et al.
Published: (2021-01-01)

Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity
by: Ida Sofie Grønningsæter, et al.
Published: (2020-05-01)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
by: Vibeke Andresen, et al.
Published: (2017-11-01)

Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: María Facenda-Lorenzo, et al.
Published: (2016-01-01)

Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis
by: Ina Nepstad, et al.
Published: (2018-09-01)

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
by: Ida Sofie Grønningsæter, et al.
Published: (2019-10-01)

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
by: Christina Rautenberg, et al.
Published: (2019-01-01)

Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers
by: Håkon Reikvam, et al.
Published: (2018-01-01)

Metabolic Serum Profiles for Patients Receiving Allogeneic Stem Cell Transplantation: The Pretransplant Profile Differs for Patients with and without Posttransplant Capillary Leak Syndrome
by: Håkon Reikvam, et al.
Published: (2015-01-01)

Isolated Extramedullary Relapse in a Case of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation
by: Raafat Abdel-Malek, et al.
Published: (2018-06-01)

Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
by: Ahmad I. Antar, et al.
Published: (2020-11-01)

Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid
by: Maria Hernandez-Valladares, et al.
Published: (2021-04-01)

Preconditioning Serum Levels of Endothelial Cell-Derived Molecules and the Risk of Posttransplant Complications in Patients Treated with Allogeneic Stem Cell Transplantation
by: Roald Lindås, et al.
Published: (2014-01-01)

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia
by: Stordrange Laila, et al.
Published: (2009-03-01)

Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia
by: Elise Aasebø, et al.
Published: (2020-03-01)

Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis
by: Knut A. Mosevoll, et al.
Published: (2018-05-01)

Proteomic Characterization of Spontaneous Stress-Induced In Vitro Apoptosis of Human Acute Myeloid Leukemia Cells; Focus on Patient Heterogeneity and Endoplasmic Reticulum Stress
by: Elise Aasebø, et al.
Published: (2021-09-01)

Extramedullary relapse of acute myeloid leukemia in brachial plexus after allogeneic stem cell transplantation: a case report
by: Imai, Y., et al.
Published: (2022)

Second allogeneic hematopoietic stem cell transplantation in treatment of relapsed acute myeloid leukemia: clinical report of 5 cases
by: LIN Shijia, et al.
Published: (2019-12-01)

SEPSIS IN ACUTE LEUKEMIA; EPIDEMIOLOGY; PATHOPHYSIOLOGY, ETIOLOGY AND TREATMENT
by: Bent-Are Hansen, et al.
Published: (2019-12-01)

Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment
by: Anh Khoi Vo, et al.
Published: (2020-01-01)

Allogeneic stem cell transplantation in acute myeloid leukemia
by: Natasha Ali, et al.
Published: (2012-11-01)

Transplantation of allogenic bone marrow in chronic myeloid leukemias
by: L S Lyubimova, et al.
Published: (2004-07-01)